-
- Topic
- Voices
- Last Post
-
- Ampio Pharmaceuticals Publishes on the Potential Benefits of Nebulized Ampion™ for COVID-19 Patients
- 0
- 6 years, 2 months ago
- Ampio Pharmaceuticals Seeks FDA Approval to Test Anti-Inflammatory Drug on COVID-19 Patients
- 0
- 6 years, 2 months ago
- Former Federal Prosecutors Share Advice on PPP Loans and Risk of Government Investigation
- 0
- 6 years, 2 months ago
- CSU Research Team Studies Poxviruses as a Means to Yield Protein Pathways for a Coronavirus Vaccine
- 0
- 6 years, 2 months ago
